Levi & Korsinsky is investigating the Board of Directors of Cornerstone
Therapeutics, Inc. (“Cornerstone” or the “Company”) (Nasdaq: CRTX) for
possible breaches of fiduciary duty and other violations of state law in
connection with a going private proposal from Chiesi Farmaceutici SpA
(“Chiesi”). Chiesi owns approximately 60% of the outstanding shares of
the Company's common stock.
Sign-up for SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches Investigation in Possible Breaches of Fiduciary Duty by the Board of Cornerstone Therapeutics, Inc. in Connection with a Going Private Proposal investment picks